We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+7.45%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$17.4B
AUM Growth
+$604M
Cap. Flow
-$350M
Cap. Flow %
-2.01%
Top 10 Hldgs %
29.23%
Holding
2,926
New
46
Increased
346
Reduced
1,409
Closed
76

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$18.5M
2
PLTR icon
Palantir
PLTR
+$14.9M
3
AVTR icon
Avantor
AVTR
+$8.33M
4
DELL icon
Dell
DELL
+$8.18M
5
AVGO icon
Broadcom
AVGO
+$6.3M

Sector Composition

Rank Sector Weight
1 Technology 29.85%
2 Financials 12.38%
3 Healthcare 11.45%
4 Consumer Discretionary 10.71%
5 Industrials 9.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRRO icon
2551
Korro Bio
KRRO
$194M
$122K ﹤0.01%
3,639
+2,050
+129% +$86.3K
NGS icon
2552
Natural Gas Services Group
NGS
$477M
$121K ﹤0.01%
6,325
+3,564
+129% +$71.2K
RMAX icon
2553
RE/MAX Holdings
RMAX
$261M
$121K ﹤0.01%
9,695
NWFL icon
2554
Norwood Financial Corp
NWFL
$378M
$121K ﹤0.01%
4,376
PROK icon
2555
ProKidney
PROK
$293M
$120K ﹤0.01%
62,660
+29,789
+91% +$67.6K
RHI icon
2556
Robert Half
RHI
$4.31B
$119K ﹤0.01%
1,772
-58
-3% -$3.67K
ONTF
2557
DELISTED
ON24
ONTF
$119K ﹤0.01%
19,516
FLWS icon
2558
1-800-Flowers.com
FLWS
$265M
$119K ﹤0.01%
15,021
LAW icon
2559
CS Disco
LAW
$292M
$119K ﹤0.01%
20,254
NCNO icon
2560
nCino
NCNO
$2.15B
$119K ﹤0.01%
3,769
-77
-2% -$2.44K
ENTA icon
2561
Enanta Pharmaceuticals
ENTA
$399M
$119K ﹤0.01%
11,454
SB icon
2562
Safe Bulkers
SB
$782M
$118K ﹤0.01%
22,845
-14,039
-38% -$72.2K
SGC icon
2563
Superior Group of Companies
SGC
$208M
$118K ﹤0.01%
7,637
+4,303
+129% +$70.1K
MED icon
2564
Medifast
MED
$131M
$118K ﹤0.01%
6,161
ESPR
2565
DELISTED
Esperion Therapeutics
ESPR
$117K ﹤0.01%
71,050
+22,734
+47% +$45.9K
HOFT icon
2566
Hooker Furnishings Corp
HOFT
$159M
$117K ﹤0.01%
6,474
RAPP
2567
Rapport Therapeutics
RAPP
$2.3B
$117K ﹤0.01%
+5,710
New +$123K
INSE icon
2568
Inspired Entertainment
INSE
$165M
$116K ﹤0.01%
12,555
TCRX icon
2569
TScan Therapeutics
TCRX
$52.4M
$116K ﹤0.01%
23,363
+13,164
+129% +$79.4K
XOMA
2570
DELISTED
Xoma
XOMA
$116K ﹤0.01%
4,371
TCX icon
2571
Tucows
TCX
$137M
$115K ﹤0.01%
5,528
-333
-6% -$7.26K
FVCB icon
2572
FVCBankcorp
FVCB
$340M
$115K ﹤0.01%
8,822
TEAD
2573
Teads Holding Co
TEAD
$63.8M
$115K ﹤0.01%
23,627
ASUR icon
2574
Asure Software
ASUR
$242M
$114K ﹤0.01%
12,593
-2,851
-18% -$25.4K
GNE icon
2575
Genie Energy
GNE
$384M
$114K ﹤0.01%
6,995
-4,497
-39% -$73.5K

Similar funds

MetLife Investment Management's Q3 2024 Portfolio in Review

As of Q3 2024, MetLife Investment Management held 2,926 positions worth $17.4B, up 3.6% from $16.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 4.2%. MetLife Investment Management opened 46 new positions and exited 76, leaving the 2,926-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q3 2024 buy was Smurfit Westrock: 128,702 shares worth $6.36M.
  • MetLife Investment Management added most to Apple in Q3 2024, an estimated $18.5M increase.
  • MetLife Investment Management's biggest Q3 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $42.3M.
  • MetLife Investment Management fully exited Diamond Offshore Drilling, Inc. in Q3 2024, selling an estimated $6.15M.
  • MetLife Investment Management's ten largest holdings make up 29% of its $17.4B portfolio in Q3 2024.
  • MetLife Investment Management opened 46 new positions and closed 76 in Q3 2024.
  • MetLife Investment Management's portfolio value rose 3.6% quarter-over-quarter to $17.4B.

Based on MetLife Investment Management's 13F filing for Q3 2024, filed 13 Nov 2024.